Patent Applications published on Mar 13, 2025 - page 3

#601
US20250082471A1
Human necessities

VALVE DELIVERY SYSTEM INCLUDING FORESHORTENING COMPENSATOR FOR IMPROVED POSITIONING ACCURACY

#602
US20250082472A1
Human necessities

HEART VALVE TREATMENT INVOLVING CHORDAE TENDINEAE CAPTURE

#603
US20250082473A1
Human necessities

Wide Clip With Nondeformable Wings

#604
US20250082474A1
Human necessities

SHAPED TISSUE GRAFT AND PROCESS TO MAINTAIN PROPERTIES

#605
US20250082475A1
Human necessities

DUAL MOBILITY ACETABULAR COMPONENT

#606
US20250082476A1
Human necessities

ELBOW JOINT PROSTHESES

#607
US20250082477A1
Human necessities

SURGICAL IMPLANT

#608
US20250082478A1
Human necessities

DRIVE INSTRUMENTS WITH RETENTION MECHANISMS, MEDICAL IMPLANTS, AND RELATED TECHNOLOGIES

#609
US20250082479A1
Human necessities

ANTI-RETROPULSION LUMBAR INTERBODY DEVICE

#610
US20250082480A1
Human necessities

TECHNOLOGIES FOR DETERMINING SEATING OF AN ORTHOPAEDIC IMPLANT DURING AN ORTHOPAEDIC SURGICAL PROCEDURE

#611
US20250082481A1
Human necessities

NERVE CONDUIT FOR PROMOTING AMPUTATED NERVE REGENERATION USING ELECTRIC FIELDS

#612
US20250082482A1
Human necessities

BALLOON CATHETERS

#613
US20250082483A1
Human necessities

DELIVERY SYSTEM FOR TUBULAR BRAIDED DEVICES

#614
US20250082484A1
Human necessities

ELECTRIC TASTE ADJUSTMENT DEVICE AND ELECTRIC TASTE TESTING DEVICE

#615
US20250082485A1
Human necessities

HINGE ASSEMBLY FOR AN ORTHOPEDIC DEVICE

#616
US20250082486A1
Human necessities

ANATOMICAL BRACE FOR DYNAMICALLY STABILIZING THE PATELLA DURING KNEE ARTICULATION SO AS TO ADDRESS PATELLA TRACKING ERROR

#617
US20250082487A1
Human necessities

SYSTEMS AND DEVICES FOR PROVIDING LIFT ASSISTANCE FOR A SURGICAL PROCEDURE

#618
US20250082488A1
Human necessities

MEDICAL SUPPORT BOOT WITH IMPROVED ANKLE AND HEEL PROTECTION

#619
US20250082489A1
Human necessities

PAEDIATRIC AND ADULT FIXATOR HAVING A PRESSURE ELEMENT

#620
US20250082490A1
Human necessities

HUMERAL FRACTURE BRACE ASSEMBLY AND ASSOCIATED METHODS

#621
US20250082491A1
Human necessities

CURETTE TOOL AND NAIL CARE METHOD USING SAME

#622
US20250082492A1
Human necessities

POST-NATAL GLUTEAL ORTHOSIS

#623
US20250082493A1
Human necessities

Regulating Flow From a Stoma on a Patient

#624
US20250082494A1
Human necessities

ReliEVE (Name). Electric Portable, Male organ-like device for women

#625
US20250082495A1
Human necessities

HEATING DEVICES

#626 ✅ Patent 12,290,469 granted on 2025-05-06
US20250082496A1
Human necessities

Portable system and device for cold therapy with optional compression therapy

#627
US20250082497A1
Human necessities

THERAPEUTIC BELT WITH POCKETS AND BALLS

#628
US20250082498A1
Human necessities

TEMPERATURE MANAGEMENT SYSTEMS

#629
US20250082499A1
Human necessities

ACTIVE DRUG DISPENSING OPHTHALMIC DEVICE HAVING A CONTROLLER-RESPONDER ARCHITECTURE

#630
US20250082500A1
Human necessities

INTRAOCULAR DEVICES AND METHODS

#631
US20250082501A1
Human necessities

IMPLANTABLE SHUNTS WITH MULTI-LAYERED FLUID RESISTORS, AND ASSOCIATED SYSTEMS AND METHODS

#632
US20250082502A1
Human necessities

TAPERED OPTICAL FIBERS FOR SURGICAL INSTRUMENTATION

#633
US20250082503A1
Human necessities

EXTERNAL FIBER FOR OPTICAL FIBER DELIVERY IN OPTHALMIC SURGICAL DEVICES

#634
US20250082504A1
Human necessities

Laser System having an Orientation Analysis System for measuring the Orientation of the Patient

#635
US20250082505A1
Human necessities

VENTILATED PROTECTIVE EYEWEAR SYSTEMS, DEVICES, AND METHODS

#636
US20250082506A1
Human necessities

Device For Extracting Nasal Mucus Or Earwax

#637
US20250082507A1
Human necessities

ELASTOMERIC PLUG FOR PATULOUS EUSTACHIAN TUBE

#638
US20250082508A1
Human necessities

METHOD OF MANUFACTURING SKIN ATTACHABLE THIN FILM COATED WITH FUNCTIONAL MIXTURE AND SKIN ATTACHABLE THIN FILM MANUFACTURED USING THE SAME

#639
US20250082509A1
Human necessities

SLEEVE FOR PLACING ON A HUMAN PENIS

#640
US20250082510A1
Human necessities

WOUND DRESSING

#641
US20250082511A1
Human necessities

Topical Compound Vacuum Film Device

#642
US20250082512A1
Human necessities

NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES AND METHODS WITH INTEGRATED ELECTRONICS

#643
US20250082513A1
Human necessities

CRYOTHERAPY DRESSING SYSTEM

#644
US20250082514A1
Human necessities

ADHESIVE EYELID CLOSURE ARTICLE

#645
US20250082515A1
Human necessities

METHOD FOR PRODUCING A MULTILAYERED ABSORBENT PRODUCT AND PRODUCT THE METHOD

#646
US20250082516A1
Human necessities

CATAMENIAL PROTECTION DEVICE AND METHOD FOR PRODUCING THE SAME

#647
US20250082517A1
Human necessities

ABSORBENT ARTICLE WITH EAR PORTION

#648
US20250082518A1
Human necessities

LIQUID BARRIER AND AIR-PERMEABLE BACKSHEET

#649
US20250082519A1
Human necessities

SANITARY NAPKIN

#650
US20250082520A1
Human necessities

FIRST AID MEDICAL TREATMENT APPARATUS AND METHOD

#651
US20250082521A1
Human necessities

Patient Transport Apparatus With Auxiliary Wheel Control Systems

#652
US20250082522A1
Human necessities

ADJUSTABLE BED ASSEMBLY HAVING A SUPPORT ATTACHMENT

#653
US20250082523A1
Human necessities

PATIENT SUPPORT APPARATUS AND MATTRESS THEREFOR

#654
US20250082524A1
Human necessities

MULTI-ALERT LIGHTS FOR HOSPITAL BED

#655
US20250082525A1
Human necessities

Patient Support Apparatuses With Controllable Wireless Charging Means To Charge Portable Electronic Devices

#656
US20250082526A1
Human necessities

PRESSURE MEASURING DEVICE, CONTROL DEVICE OF IRRADIATION DEVICE AND CONTROL SYSTEM OF PRESSURE MEASUREMENT BASED IRRADIATION DEVICE

#657
US20250082527A1
Human necessities

MATTRESS DEGRADATION DETERMINATION USING RADAR

#658
US20250082528A1
Human necessities

PATIENT SUPPORT APPARATUS WITH NOTIFICATION SYSTEM

#659
US20250082529A1
Human necessities

CARE BED

#660
US20250082530A1
Human necessities

TIME-BASED WIRELESS PAIRING BETWEEN A MEDICAL DEVICE AND A WALL UNIT

#661
US20250082531A1
Human necessities

EQUIPMENT FOR THE TRANSPORT OF BIOMEDICAL DEVICES

#662
US20250082532A1
Human necessities

MEDICAL FIXATION DEVICE FOR CONNECTING SURGICAL INSTRUMENTS TO AN OPERATING TABLE

#663
US20250082533A1
Human necessities

Environmentally Friendly and Quickly Assembled Flat Pack Coffin

#664
US20250082534A1
Human necessities

BODY BAG FOR USE IN ALKALINE HYDROLYSIS

#665
US20250082535A1
Human necessities

MASSAGE DEVICES, MASSAGE ELEMENTS, AND METHODS FOR RELIEVING SOFT TISSUE PAIN AND TENSION

#666
US20250082536A1
Human necessities

STIMULATION DEVICE HAVING AN APPENDAGE

#667
US20250082537A1
Human necessities

Multipurpose Ergonomic Massage Tool With Shallow Entry, Dilation And Clitoral Stimulation

#668
US20250082538A1
Human necessities

INTERACTIVE SEX TOY WITH SENSORY FEEDBACK

#669
US20250082539A1
Human necessities

INTRAGASTRIC MAGNETIC DEVICE AND EXTERNAL STIMULATOR

#670
US20250082540A1
Human necessities

MASSAGE APPLICATOR HEAD ASSEMBLY

#671
US20250082541A1
Human necessities

LIFE WAVES FOR THERAPY AND USES THEREOF

#672
US20250082542A1
Human necessities

LIGHTING FOR MECHANICAL CPR DEVICE

#673
US20250082543A1
Human necessities

REMOTE SPA CONTROL SYSTEM

#674
US20250082544A1
Human necessities

ADAPTER FOR USE IN A PLANETARY MIXER

#675
US20250082545A1
Human necessities

GLASS CONTAINERS FOR STORING PHARMACEUTICAL COMPOSITIONS

#676
US20250082546A1
Human necessities

DISPENSING SYSTEM

#677
US20250082547A1
Human necessities

System and Method for Medication Management

#678
US20250082548A1
Human necessities

INFANT FEEDER

#679
US20250082549A1
Human necessities

X-RAY OPAQUE FILLER MATERIAL, X-RAY OPAQUE DENTAL FILLER MATERIAL, METHOD FOR PRODUCING X-RAY OPAQUE FILLER MATERIAL, AND CURABLE DENTAL COMPOSITION

#680
US20250082550A1
Human necessities

BIFUNCTIONAL AND POLYFUNCTIONAL COINITIATORS IN DENTAL COMPOSITIONS

#681
US20250082551A1
Human necessities

CATIONIC LIPOSOME FOR ENHANCING SKIN ABSORPTION AND PREPARATION METHOD THEREFOR

#682
US20250082552A1
Human necessities

Dental Care Products Comprising Stannous Flouride

#683
US20250082553A1
Human necessities

Tooth Surface Treating Agent and Tooth Surface Treating Kit

#684
US20250082554A1
Human necessities

PIGMENT COMPOSITION, COSMETIC MATERIAL, INK, COATING MATERIAL, TONER, AND MOLDED ARTICLE

#685
US20250082555A1
Human necessities

PROCESS FOR DYEING KERATIN FIBRES USING A COSMETIC COMPOSITION COMPRISING PROPANE-1,3-DIOL AND A DYEING COMPOSITION

#686
US20250082556A1
Human necessities

PROCESS FOR REMOVING MAKEUP FROM KERATIN FIBRES WHICH HAVE BEEN TREATED BEFOREHAND WITH A COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER

#687
US20250082557A1
Human necessities

COMPOSITION FOR ENHANCING SKIN VITALITY CONTAINING A THYMOL ESTER-BASED COMPOUND

#688
US20250082558A1
Human necessities

COSMETIC PRODUCT OF PACKAGING AND A PREPARATION CONTAINING 1,2-PROPANE DIOL ESTER

#689
US20250082559A1
Human necessities

EXTERNAL-USE SKIN PREPARATION COMPOSITION

#690
US20250082560A1
Human necessities

PARTICLES AND USE THEREOF

#691
US20250082561A1
Human necessities

IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS

#692
US20250082562A1
Human necessities

PROTONATED AND DEPROTONATED POLYETHYLENIMINE APPARATUS AND METHOD OF USE THEREOF

#693
US20250082563A1
Human necessities

ANHYDROUS COMPOSITION FOR SKINCARE AND/OR ANTI-TRANSFER MAKEUP

#694
US20250082564A1
Human necessities

OIL-IN-WATER EMULSION COSMETIC

#695
US20250082565A1
Human necessities

ANTIOXIDANT COSMETIC COMPLEX, COSMETIC COMPOSITION, USE AND METHOD FOR COSMETIC TREATMENT

#696
US20250082566A1
Human necessities

TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

#697
US20250082567A1
Human necessities

FACIAL COSMETIC COMPOSITIONS AND METHODS OF IMPROVING FACIAL AESTHETICS

#698
US20250082568A1
Human necessities

DEVICES AND METHODS FOR REDUCING CYSTINE CRYSTALS IN VIVO

#699
US20250082569A1
Human necessities

ORALLY DISINTEGRATING NICOTINE TABLET WITH LOW AMOUNT OF FLAVOR

#700
US20250082570A1
Human necessities

COMBINATION THERAPY FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE

#701
US20250082571A1
Human necessities

COMPOSITIONS AND METHODS FOR DELIVERY OF IL-2 AND ANTI-IL-2 FOR TREATMENT OF RHEUMATOID ARTHRITIS

#702
US20250082572A1
Human necessities

TOPICAL FORMULATIONS FOR HANDLING ATOPIC DERMATITIS

#703
US20250082573A1
Human necessities

COMPOSITIONS AND METHODS FOR DELIVERY OF OCULAR THERAPEUTICS

#704
US20250082574A1
Human necessities

INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES

#705
US20250082575A1
Human necessities

GAMMA POLYGLUTAMATED PRALATREXATE AND USES THEREOF

#706
US20250082576A1
Human necessities

CATIONIC LIPID COMPOUND, COMPOSITION CONTAINING SAME AND USE THEREOF

#707
US20250082577A1
Human necessities

POLYMER BEADLET COMPOSITIONS AND METHODS OF USE THEREOF FOR IMPROVED STABILITY, BIOAVAILABILITY & SUSTAINED RELEASE

#708
US20250082578A1
Human necessities

VIRAL VECTOR STABILIZATION

#709
US20250082579A1
Human necessities

ORALLY DISINTEGRATING NICOTINE TABLET FOR USE UNDER LIP

#710
US20250082580A1
Human necessities

CONTROLLED-RELEASE ORAL FORMULATION AND PREPARATION METHOD THEREOF

#711 ✅ Patent 12,280,152 granted on 2025-04-22
US20250082581A1
Human necessities

Tamper resistant dosage forms

#712
US20250082582A1
Human necessities

POLYMER-ENCAPSULATED DRUG PARTICLES

#713
US20250082583A1
Human necessities

MICROCAPSULE AND PREPARATION METHOD AND USE THEREOF

#714
US20250082584A1
Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF SELEXIPAG

#715
US20250082585A1
Human necessities

METHOD FOR STORING REDUCED COENZYME Q10

#716
US20250082586A1
Human necessities

COMPOSITIONS FOR TREATING INFLAMMATORY, NEUROLOGIC AND/OR VASCULAR CONDITIONS AND METHODS OF USE THEREOF

#717
US20250082587A1
Human necessities

Method Of Treating Major Depressive Disorder

#718
US20250082588A1
Human necessities

PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER

#719
US20250082589A1
Human necessities

PHENYLETHYLIDENEHYDRAZINE DIMERS AND METHODS OF USING SAME

#720 ✅ Patent 12,364,675 granted on 2025-07-22
US20250082590A1
Human necessities

TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE

#721
US20250082591A1
Human necessities

LIDOCAINE-CONTAINING PATCH

#722
US20250082592A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF SARCOPENIA, CONTAINING ROR-alpha ACTIVATOR JC1-40

#723
US20250082593A1
Human necessities

HALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF

#724
US20250082594A1
Human necessities

COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM BODY SURFACE LESIONS AND FROM ORAL CAVITY

#725
US20250082595A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING PARKINSON’S DISEASE

#726
US20250082596A1
Human necessities

Methods and Compositions for Treatment of Inflammatory Disease

#727
US20250082597A1
Human necessities

METHOD FOR TREATING TAUOPATHY IN THE BRAIN, BRAIN STEM AND SPINAL COLUMN

#728
US20250082598A1
Human necessities

Melafenoxate, 2-(1-adamantylamino)ethyl 2-(4-chlorophenoxy)acetate and derivatives thereof for treating circadian rhythm sleep disorders with neurodegenerative diseases such as Alzheimer's disease

#729
US20250082599A1
Human necessities

GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD

#730
US20250082600A1
Human necessities

TREATING HAEMATOLOGICAL MALIGNANCIES BY MEANS OF SATRAPLATIN

#731
US20250082601A1
Human necessities

Significantly non-toxic novel Cobalt(III) Schiff base complex induces apoptosis via G2-M cell cycle arrest in human breast cancer cell line MCF-7 and cell cycle arrest of colon cancer cell lines HCT-116 and SW- 480 via G0-G1

#732
US20250082602A1
Human necessities

OPHTHALMIC COMPOSITION CONTAINING RECOFLAVONE FOR THE TREATMENT OF DRY EYE DISEASE

#733
US20250082603A1
Human necessities

OPHTHALMIC COMPOSITION CONTAINING RECOFLAVONE FOR THE TREATMENT OF DRY EYE DISEASE AND METHOD FOR PREPARING THE SAME

#734
US20250082604A1
Human necessities

COMPOSITIONS CONTAINING A HIGH CONTENT OF PROANTHOCYANIDINS AND METHODS OF PREPARATION AND USE THEREOF

#735
US20250082605A1
Human necessities

Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin

#736
US20250082606A1
Human necessities

ANTIBACTERIAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS

#737
US20250082607A2
Human necessities

METHODS OF TREATING DISORDERS WITH A PSILOCYBIN ANALOG

#738
US20250082608A1
Human necessities

TREATMENT AND PREVENTION OF GLOMERULAR DISEASE

#739
US20250082609A1
Human necessities

HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF

#740
US20250082610A1
Human necessities

COMPOSITION, METHOD FOR MICROORGANISM GROWTH SUPPRESSION IN COMPOSITION FOR ORAL USE, AND AGENT FOR POTENTIATION OF MICROORGANISM-GROWTH-SUPPRESSING EFFECT OF QUERCETIN OR GLYCOSIDE THEREOF

#741
US20250082611A1
Human necessities

DOSING REGIMEN FOR AN NLRP3 INHIBITOR IN THE TREATMENT OF OSTEOARTHRITIS

#742
US20250082612A1
Human necessities

SREBP-1 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTRIGLYCERIDEMIA

#743
US20250082613A1
Human necessities

TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL

#744
US20250082614A1
Human necessities

METHODS OF USING RAD51 INHIBITORS FOR TREATMENT OF PANCREATIC CANCER

#745
US20250082615A1
Human necessities

SOLID DISPERSION OF RIFAXIMIN

#746
US20250082616A1
Human necessities

Solid Dispersion Forms of Rifaximin

#747
US20250082617A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF APIXABAN

#748
US20250082618A1
Human necessities

DOSING REGIMENS USING TOPICAL ROFLUMILAST COMPOSITIONS

#749
US20250082619A1
Human necessities

USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE

#750
US20250082620A1
Human necessities

NOVEL CINNAMAMIDE DERIVATIVES AND USE THEREOF

#751
US20250082621A9
Human necessities

Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases

#752
US20250082622A1
Human necessities

BUPIVACAINE LIQUID FORMULATIONS

#753
US20250082623A1
Human necessities

COMPOSITIONS CONTAINING FEXOFENADINE

#754
US20250082624A1
Human necessities

METHODS OF TREATING COGNITIVE IMPAIRMENT

#755
US20250082625A1
Human necessities

NOVEL THERAPY

#756
US20250082626A1
Human necessities

TESOFENSINE AND METOPROLOL FOR TREATMENT OF HYPERTENSION

#757
US20250082627A1
Human necessities

TOBACCO HARM REDUCTION AND PAIN RELIEF PRODUCTS AND METHODS THEREOF

#758
US20250082628A1
Human necessities

INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)

#759
US20250082629A1
Human necessities

ANTIPROLIFERATIVE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE

#760
US20250082630A1
Human necessities

METHODS OF TREATING BRAIN TUMOURS AND NEUROBLASTOMAS

#761
US20250082631A1
Human necessities

SLEEP IMPROVING AGENT

#762
US20250082632A1
Human necessities

TREATMENT OF PROSTATE CANCER

#763
US20250082633A1
Human necessities

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#764
US20250082634A1
Human necessities

PIM KINASE INHIBITORS FOR TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS AND FIBROSIS ASSOCIATED WITH CANCER

#765
US20250082635A1
Human necessities

METHOD OF TREATING DEPRESSION USING SELTOREXANT

#766
US20250082636A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA

#767
US20250082637A1
Human necessities

Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)pi-perazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and potassium ions

#768
US20250082638A1
Human necessities

Dosing Regime For Treatment of Chronic Hand Eczema

#769
US20250082639A1
Human necessities

ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

#770
US20250082640A1
Human necessities

Therapeutics for Hyponatremia and Polycystic Kidney Disease

#771
US20250082641A1
Human necessities

A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SGLT2 INHIBITOR AND DPP-IV INHIBITOR

#772
US20250082642A1
Human necessities

TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG

#773
US20250082643A1
Human necessities

COMBINATION THERAPY FOR PIK3CA-ASSOCIATED DISEASES OR DISORDERS

#774
US20250082644A1
Human necessities

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

#775
US20250082645A1
Human necessities

IRAK4 DEGRADERS AND USES THEREOF

#776
US20250082646A1
Human necessities

OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF

#777
US20250082647A1
Human necessities

SPECIFIC DOSAGE OF PHENOTHIAZINE COMPOUNDS FOR USE IN TREATMENT OR PREVENTION OF ALZHEIMER'S DEMENTIA

#778
US20250082648A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING KRAS INHIBITOR OR SHP2 INHIBITOR EFFICACY

#779
US20250082649A1
Human necessities

ALTERATION OF NUTRIENT PREFERENCES VIA MODULATION OF NUTRIENT RECEPTORS IN THE GUT

#780
US20250082650A1
Human necessities

COMBINED USE OF MULTIKINASE INHIBITOR

#781
US20250082651A1
Human necessities

GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS

#782
US20250082652A1
Human necessities

SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES

#783
US20250082653A1
Human necessities

THERAPEUTIC PRODUCT IN THE FORM OF A DENTAL GEL

#784
US20250082654A1
Human necessities

AZD3355 (LESOGABERAN) FOR TREATMENT AND PREVENTION OF NONALCOHOLIC STEATOHEPATITIS (NASH), LIVER FIBROSIS, AND OTHER LIVER CONDITIONS

#785
US20250082655A1
Human necessities

USE OF HETEROCYCLIC COMPOUND

#786
US20250082656A1
Human necessities

DOSAGE REGIMENS FOR TREATMENT OF DENGUE INFECTION

#787
US20250082657A1
Human necessities

CONJUGATES OF CHEMOTHERAPY AGENTS AND TISSUE-BINDING SMALL MOLECULES, COMPOSITIONS AND METHODS THEREOF

#788
US20250082658A1
Human necessities

CELL PROLIFERATION RETARDANT, COSMETIC CONTAINING SAME, AND CELL PROLIFERATION RETARDATION METHOD

#789
US20250082659A1
Human necessities

MANNO-OLIGOSACCHARIDE COMPOSITIONS FOR PATHOGEN CONTROL

#790
US20250082660A1
Human necessities

Active Ingredient Group For Treating Constipation

#791
US20250082661A1
Human necessities

ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF

#792
US20250082662A1
Human necessities

COMPOSITION FOR TREATING BLOOD CANCER USING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND USES THEREOF

#793
US20250082663A1
Human necessities

COMPOUNDS AND METHODS FOR TREATING OR PREVENTING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD), AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE (ADPLD) AND/OR AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD)

#794
US20250082664A1
Human necessities

NUCLEOSIDE FORMULATION

#795
US20250082665A1
Human necessities

EYE DROP FORMULATIONS IN THE FORM OF AN AQUEOUS SOLUTION COMPRISING 8-OXO-2'-DEOXYGUANOSINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#796 ✅ Patent 12,280,070 granted on 2025-04-22
US20250082666A1
Human necessities

Drugs for prevention or treatment of sepsis

#797
US20250082667A1
Human necessities

THERAPEUTIC AGENTS FOR TREATMENT OF CORONAVIRUS INFECTION

#798
US20250082668A1
Human necessities

POLYSACCHARIDE-POLYAMINE COPOLYMERS FOR REMOVAL OF PHOSPHATE

#799
US20250082669A1
Human necessities

POVIDONE IODINE SOLUTION AND GEL, PREPARATION METHOD AND APPLICATION THEREOF

#800
US20250082670A1
Human necessities

Livestock Feed Additives to Mitigate the Environmental Impact of Ruminants

#801
US20250082671A1
Human necessities

ANIMAL FEED ADDITIVE COMPOSITION, PRE-MIX FEED COMPOSITION AND MANUFACTURING METHOD FOR SUB CLINICAL HYPCALCEMIA RELIEF, ENERGY IMPROVEMENT AND INCREASED MILK PRODUCTION

#802
US20250082672A1
Human necessities

METAL (HYDR) OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#803
US20250082673A1
Human necessities

COLON LAVAGE SYSTEM

#804
US20250082674A1
Human necessities

METHODS OF TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS

#805
US20250082675A1
Human necessities

TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE

#806
US20250082676A1
Human necessities

TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE

#807
US20250082677A1
Human necessities

LONG COVID MEDICATION AND METHOD OF TREATMENT

#808
US20250082678A1
Human necessities

BIOAVAILABLE MIXTURE PROVIDING SAFE, BROAD-SPECTRUM, ANTIPATHOGENIC, HEALTH, FITNESS, NEUROLOGICAL, AND HOMEOSTATIC BENEFITS

#809
US20250082679A1
Human necessities

Method of Targeting Cells and Associated Compositions

#810
US20250082680A1
Human necessities

TCR AND APPLICATION THEREOF

#811
US20250082681A1
Human necessities

ANTIBODIES AGAINST CLL1 AND CONSTRUCTS THEREOF

#812
US20250082682A1
Human necessities

SYSTEMS OF ENGINEERED RECEPTORS TARGETING PSMA AND CA9

#813
US20250082683A1
Human necessities

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

#814
US20250082684A1
Human necessities

Recombinant Cell Line Expressing Membrane Proteins and Vesicles Prepared Therefrom

#815
US20250082685A1
Human necessities

METHODS FOR ATTENUATING VIRAL INFECTION AND FOR TREATING LUNG INJURY

#816
US20250082686A1
Human necessities

AAV-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF

#817
US20250082687A1
Human necessities

COMPOSITION FOR IMPROVING MEMORY OR COGNITIVE ABILITY, OR PREVENTING OR TREATING BRAIN NEUROLOGICAL DISEASE, COMPRISING PORCINE BRAIN ENZYME HYDROLYSATE

#818
US20250082688A1
Human necessities

COMPOSITIONS AND METHODS FOR WILLIAMS SYNDROME (WS) THERAPY

#819
US20250082689A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING CARDIOMYOCYTE TRANSPLANT ENGRAFTMENT

#820
US20250082690A1
Human necessities

SHEET-SHAPED CELL CULTURE FOR TREATING LIVER DYSFUNCTION

#821
US20250082691A1
Human necessities

MICRONIZED EGGSHELL MEMBRANE PARTICLES AND THE USE THEREOF TO PROMOTE THE HEALING OF WOUNDS

#822
US20250082692A1
Human necessities

ENGINEERED MICROORGANISM FOR TREATING HYPERPHENYLALANINEMIA AND USE THEREOF

#823
US20250082693A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS

#824
US20250082694A1
Human necessities

PROBIOTICS FOR USE IN BOOSTING THE IMMUNE SYSTEM

#825
US20250082695A1
Human necessities

USE OF GLYCEROL FOR INCREASING BUTYRATE PRODUCTION BY BACTERIA IN A CONSORTIUM

#826
US20250082696A1
Human necessities

METHOD FOR PROVIDING RELIEF FROM FRUCTAN OR FRUCTOSE INDUCED ABDOMINAL DISCOMFORT

#827
US20250082697A1
Human necessities

Compositions and Methods for Diagnosing Susceptibility to Autism Spectrum Disorder (ASD), Reducing the Likelihood of Developing ASD, and/or Treating ASD

#828
US20250082698A1
Human necessities

BACTERIAL COMPOSITIONS FOR TREATING AND PREVENTING HALITOSIS

#829
US20250082699A1
Human necessities

Bifidobacterium Longum Subsp. Infantis CCFM1269 and Application thereof

#830
US20250082700A1
Human necessities

METHODS AND COMPOSITIONS OF TREATING BIOLFILM-RELATED DISEASES

#831
US20250082701A1
Human necessities

METHODS AND COMPOSITIONS FOR HONEY BEE HEALTH

#832
US20250082702A1
Human necessities

ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX

#833
US20250082703A1
Human necessities

GINKGO BILOBA KETONE ESTER CAPSULE AND PREPARATION METHOD THEREOF

#834
US20250082704A1
Human necessities

MAQUI BERRY EXTRACTS FOR USE IN THE TREATMENT OR PREVENTION OF BONE DISORDERS

#835
US20250082705A1
Human necessities

COMPOSITION FOR IMPROVING, PREVENTING, OR TREATING SLEEP DISORDERS COMPRISING DENDROPANAX MORBIFERA EXTRACTS

#836
US20250082706A1
Human necessities

FERMENTED GINSENG RADIX ET RHIZOMA EXTRACT, PRODUCT FOR ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE, METHOD FOR PROMOTING INCREASE OF CONTENT OF AGLYCONE FLAVONOIDS AND/OR SHORT-CHAIN FATTY ACIDS IN GINSENG RADIX ET RHIZOMA EXTRACT, AND METHOD FOR PROMOTING EFFICACY OF GINSENG RADIX ET RHIZOMA EXTRACT IN ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE

#837
US20250082707A1
Human necessities

COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY AND SARCOPENIA, COMPRISING RHODODENDRON MUCRONULATUM EXTRACT AS ACTIVE INGREDIENT

#838
US20250082708A1
Human necessities

HERBAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF POSTPARTUM DEPRESSION

#839
US20250082709A1
Human necessities

ARTIFICIAL TEARS AND THERAPEUTIC USES

#840
US20250082710A1
Human necessities

Composition for Relieving Sleep Disorder and its Application Method Thereof

#841 ✅ Patent 12,280,085 granted on 2025-04-22
US20250082711A1
Human necessities

Herbal composition PHY906 and its use in chemotherapy

#842
US20250082712A1
Human necessities

WITHANIA SOMNIFERA AND ASPARAGUS RACEMOSUS IN TREATING POST-MENOPAUSAL CONDITIONS

#843
US20250082713A1
Human necessities

Active ingredient groups and their key target combinations for the treatment of UC

#844
US20250082714A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF MUSCULAR DYSTROPHY

#845
US20250082715A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE LUNG INJURY

#846
US20250082716A1
Human necessities

REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION

#847
US20250082717A1
Human necessities

COMPOSITIONS FOR TREATING KIDNEY DISEASE

#848
US20250082718A1
Human necessities

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

#849
US20250082719A1
Human necessities

ISOCYCLOSPORIN A FOR TOPICAL TREATMENT OF OCULAR DISEASES

#850
US20250082720A1
Human necessities

NEW PEPTIDE AND USES THEREOF

#851
US20250082721A1
Human necessities

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING PARKINSON'S DISEASE COMPRISING OSMOTIN PROTEIN AS EFFECTIVE COMPONENT

#852
US20250082722A1
Human necessities

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

#853
US20250082723A1
Human necessities

METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF TUMORS

#854
US20250082724A1
Human necessities

VERSATILE IMMUNOGENIC MODULES AND NANOPARTICLES FOR TICK VACCINES

#855
US20250082725A1
Human necessities

METHODS FOR PREVENTING AND TREATING BRAIN INFLAMMATION

#856
US20250082726A1
Human necessities

VEGFR-FC FUSION PROTEIN FORMULATIONS

#857
US20250082727A1
Human necessities

CXCL14-BASED COMPOSITIONS AND METHOD FOR ENHANCING CARTILAGE REGENERATION

#858
US20250082728A1
Human necessities

INTERLEUKIN 4 AND/OR INTERLEUKIN 13-BASED EYE COMPOSITIONS

#859
US20250082729A1
Human necessities

BIOMARKERS AND TREATMENT METHODS FOR TRAUMATIC BRAIN INJURY-ASSOCIATED IMPAIRMENTS

#860
US20250082730A1
Human necessities

TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39)

#861
US20250082731A1
Human necessities

TRANSDERMAL INSULIN FORMULATIONS AND METHODS OF USE THEREOF

#862
US20250082732A1
Human necessities

ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS FOR TREATING ENTERIC DISEASES IN ANIMALS

#863
US20250082733A1
Human necessities

m6A mRNA MODIFICATION IN CANCER TREATMENT

#864
US20250082734A1
Human necessities

PTPRS IN AUTOIMMUNITY

#865
US20250082735A1
Human necessities

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

#866
US20250082736A1
Human necessities

PARTICLES AND SUSPENSIONS COMPRISING HYALURONAN DEGRADING AGENTS AND METHODS OF USE THEREOF

#867
US20250082737A1
Human necessities

ACE2 FUSION PROTEINS AND USES THEREOF

#868
US20250082738A1
Human necessities

TREATMENT OF VISCERAL PAIN

#869
US20250082739A1
Human necessities

METHODS FOR DESIGNING IMMUNOTHERAPIES AND TREATMENTS USING SAME

#870
US20250082740A1
Human necessities

USE OF CXCL14

#871
US20250082741A1
Human necessities

Listeria Variants and Methods of Use Thereof

#872
US20250082742A1
Human necessities

MRNA THERAPEUTIC COMPOSITIONS

#873
US20250082743A1
Human necessities

VIRAL VECTORED VACCINES FOR SWINE INFLUENZA VIRUS AND METHODS OF USE

#874
US20250082744A1
Human necessities

CHIMERIC INFLUENZA VACCINES

#875
US20250082745A1
Human necessities

BACTERIOPHAGE LAMBDA-VACCINE SYSTEM

#876
US20250082746A1
Human necessities

CIRCULAR RNA VACCINES AGAINST SARS-COV-2 VARIANTS AND METHODS OF USE THEREOF

#877
US20250082747A1
Human necessities

PORCINE CORONAVIRUS VACCINES

#878
US20250082748A1
Human necessities

HUMAN CYTOMEGALOVIRUS RNA VACCINES

#879
US20250082749A1
Human necessities

Vaccine Adjuvant

#880
US20250082750A1
Human necessities

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST

#881
US20250082751A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITING PATHOGEN INFECTION

#882
US20250082752A1
Human necessities

COMPOUNDS, TARGETS, AND METHODS FOR MODULATING LYTIC GRANULE CONVERGENCE IN CYTOTOXIC CELLS TO PROMOTE BYSTANDER KILLING IN CELLULAR THERAPIES

#883
US20250082753A1
Human necessities

CHIMERIC RECEPTORS

#884
US20250082754A1
Human necessities

ANTI-CD33 ANTIBODIES AND USES THEREOF

#885
US20250082755A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF CANCER

#886
US20250082756A1
Human necessities

MUC16 CHIMERIC ANTIGEN RECEPTORS

#887
US20250082757A1
Human necessities

POLYMER MOLECULE, MONOMERIC STRUCTURE AND POLYMERIC STRUCTURE COMPRISING SAME

#888
US20250082758A1
Human necessities

INSULIN CONJUGATES

#889
US20250082759A1
Human necessities

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND TARGETED SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS

#890
US20250082760A1
Human necessities

DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#891
US20250082761A1
Human necessities

DUAL-TARGETED RNA POLYMERASE INHIBITORS: CONJUGATES OF BENZOXAZINO- AND SPIRO-RIFAMYCINS WITH N ALPHA-AROYL-N-ARYL-PHENYLALANINAMIDES

#892
US20250082762A1
Human necessities

NOVEL BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF

#893
US20250082763A1
Human necessities

COMBINATION DRUG FOR TREATING TRIPLE-NEGATIVE BREAST CANCER

#894
US20250082764A1
Human necessities

DRUG FOR TREATING TRIPLE NEGATIVE BREAST CANCER

#895
US20250082765A1
Human necessities

MOLECULES AS ANTICANCER AGENTS FOR TARGETED TREATMENT OF BREAST AND PROSTATE CANCER

#896
US20250082766A1
Human necessities

TREATMENT OF BRAIN TUMORS BY TARGETING THE CHOLESTEROL PATHWAY IN ASTROCYES

#897
US20250082767A1
Human necessities

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS

#898
US20250082768A1
Human necessities

CONJUGATING REAGENTS AND CONJUGATES THEREOF

#899
US20250082769A1
Human necessities

CELLULAR UPTAKE PEPTIDE-THERAPEUTIC PAYLOAD COMPOSITIONS AND METHODS OF USE

#900
US20250082770A1
Human necessities

ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING CARCINOEMBYRONIC ANTIGEN